• Font Size    
E-mail

Close Window E-mail This Page

FDA Advisers Suggest Restricting Some Asthma Drugs

Required fields are marked with an asterisk(*)

The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

Send E-mail

   Print     Share +    Comments
Dec 11, 2008 10:20 am US/Pacific

FDA Advisers Suggest Restricting Some Asthma Drugs

WASHINGTON (AP) ― FDA advisers say some long-acting asthma drugs are too risky.

Medical and scientific advisers to the Food and Drug Administration on Thursday recommended that Foradil and Serevent no longer be used for asthma. But they spared Advair, the top-selling drug in the group.

All the medications contain an ingredient that relaxes muscles around stressed airways. But that may mask symptoms that can trigger life-threatening asthma attacks. Advair contains a second ingredient that reduces inflammation inside breathing passages and may help patients avoid problems.

The FDA's drug safety experts had recommended restrictions, but its respiratory specialists said none were needed. The FDA usually follows the recommendations of its outside advisers.

(© 2009 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)

Add Comment

here. here. Need a log in? Register here
  •  * Will not be displayed with comment
  •  * e.g. (http://www.mywebsite.com)
  •  
  • Click here to refresh with new letters

Show Comments (0)

Close Window Login


Close Window Flag Comment


loading...
You need the latest Flash player to view video content.
Click here to download.

Click here to bypass this detection if you already have the latest Flash Player.

U.S. & World

Top News Stories

© MMIX, CBS Broadcasting Inc. All Rights Reserved.